Specimen · Stack · 2 components
BPC-157 + KPV (Gut Stack)
Also called: BPC-157 + KPV · Gut healing stack
AnecdotalUnclear⚠ none in humans
A digestion-focused combination people run for gut and inflammatory-bowel complaints, pairing BPC-157's gut-repair reputation with KPV's anti-inflammatory action.
What's in the BPC-157 + KPV (Gut Stack) stack
Why people combine them
This stack targets the gut specifically. BPC-157's oldest and most-replicated animal finding is protection and healing of the GI tract, and KPV is a short anti-inflammatory peptide (a fragment of alpha-MSH) studied in models of intestinal inflammation. The community rationale is to combine tissue repair with inflammation control for digestive issues — a plausible pairing on mechanism, but untested together in humans.
The BPC-157 + KPV gut stack is the digestion-focused combination in the peptide world. It pairs BPC-157 — whose most-replicated animal finding is protecting and healing the GI tract — with KPV, a small anti-inflammatory peptide studied in models of intestinal inflammation. The community idea is straightforward: repair the tissue and calm the inflammation at the same time.
On mechanism it’s a plausible pairing, but the combination has never been tested together in a human trial, so the stack itself is anecdotal. Anyone dealing with real inflammatory-bowel disease has a strong reason to work with a clinician rather than self-treating with research chemicals. The compatibility note below flags that no stability data covers combining these two in one syringe.
What the evidence says
As a combination, the BPC-157 + KPV (Gut Stack) stack has no controlled human trials behind it — the components are studied mostly on their own, and running them together is community practice, not a tested protocol. We grade the stack itself anecdotal.
Can these share a syringe?
Whether the components can be drawn into one injection is a separate, physical question from whether the stack is a good idea. Here's what's known for these pairs — and ourmixing-compatibility reference covers every pairing, with "insufficient data" wherever the research is genuinely silent.
BPC-157 + KPV
Insufficient data on combining in one syringe
No stability study covers this pair; treat combining as insufficient-data and keep separate unless you have a real reason not to. See the mixing-compatibility tool.
Safety & regulatory notes
Both are research chemicals without long-term human safety data, and the combination has none. People with active GI disease should be especially cautious about self-treating with unregulated compounds instead of established medical care. Oral and injectable forms are both marketed; the animal gut work used varied routes.
Both BPC-157 and KPV are research-use-only in the US — neither is FDA-approved and neither is a legal dietary supplement. Re-verify status after the July 2026 FDA advisory-committee outcome.
Preparing the components
Each component is a lyophilized powder that has to be reconstituted before use. Ourreconstitution & dosing calculatorturns vial size, water, and target dose into the exact insulin-syringe units to draw, and the cost-per-dose calculator shows what a full cycle runs.